MCKESSON CORP (MCK) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:MCK - US58155Q1031 - Common Stock
MCK Key Statistics, Chart & Performance
The current stock price of MCK is 816.06 USD. In the past month the price increased by 0.36%. In the past year, price increased by 40.28%.
MCK Latest News, Press Relases and Analysis
MCK Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COR | CENCORA INC | 20.99 | 65.12B | ||
| CAH | CARDINAL HEALTH INC | 22.57 | 47.78B | ||
| HSIC | HENRY SCHEIN INC | 16.11 | 9.14B | ||
| AHCO | ADAPTHEALTH CORP | 32.78 | 1.42B | ||
| WGRX | WELLGISTICS HEALTH INC | N/A | 35.25M |
Related stock screener links
About MCK
Company Profile
McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
Company Info
MCKESSON CORP
6555 State Highway 161
Irving TEXAS 75039 US
CEO: Brian S. Tyler
Employees: 48000
Phone: 19724464800
MCKESSON CORP / MCK FAQ
What does MCKESSON CORP do?
McKesson Corp. engages in providing healthcare services. The company is headquartered in Irving, Texas and currently employs 43,000 full-time employees. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. The company also offers oncology and specialty solutions.
What is the current price of MCK stock?
The current stock price of MCK is 816.06 USD. The price increased by 0.18% in the last trading session.
Does MCK stock pay dividends?
MCKESSON CORP (MCK) has a dividend yield of 0.4%. The yearly dividend amount is currently 2.71.
What is the ChartMill rating of MCKESSON CORP stock?
MCK has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the sector and industry classification for MCKESSON CORP?
MCKESSON CORP (MCK) operates in the Health Care sector and the Health Care Providers & Services industry.
Can you provide the number of employees for MCKESSON CORP?
MCKESSON CORP (MCK) currently has 48000 employees.
What is the market capitalization of MCK stock?
MCKESSON CORP (MCK) has a market capitalization of 100.73B USD. This makes MCK a Large Cap stock.
MCK Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to MCK. When comparing the yearly performance of all stocks, MCK is one of the better performing stocks in the market, outperforming 82.63% of all stocks.
MCK Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to MCK. MCK has an average financial health and profitability rating.
MCK Financial Highlights
Over the last trailing twelve months MCK reported a non-GAAP Earnings per Share(EPS) of 36.27. The EPS increased by 25.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.04% | ||
| ROA | 4.79% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MCK Forecast & Estimates
22 analysts have analysed MCK and the average price target is 955.45 USD. This implies a price increase of 17.08% is expected in the next year compared to the current price of 816.06.
For the next year, analysts expect an EPS growth of 18.06% and a revenue growth 12.63% for MCK